The chart suggests SOL will outperform on gross margin in the future.
No idea where the chart comes from and what quality the underlying analysis has (There is lot of crap out there). However it seems intuitive to me that SOL will reap higher GMs since a big chunk of the business is poly manufacturing and they seem to have a good cost position in it. On the other hand I don't agree with the GM premium for Trina on the chart, thus I question the quality of the analysis altogether.
Found it: http://apgreenjobs.ilo.org/resources/saved/at_download/file1
Original source: http://www.greentechmedia.com/research/report/pv-supply-2012
Looks like one of those reports/analysis that focuses more on quantity than quality of numbers.
On gross margin I agree, best way to get a high gross margin is if you can make poly at low cost. If you can make high quality wafers at low cost you can increase revenue and profits while retaining good gross margin.
This is what GCL has done. Let's call poly and wafer upstream and cell and module the midstream, then EPC and project development the downstream. So having upstream capacity you get a good average gross margin over a full industry cycle, but it can be volatile as relative pricing cycles hardest upstream and underutilization of expensive upstream capacity costs a lot and the outsourced upstream capacity of midstream operators would normally be hit before their in-house capacity. So what GCL does is that it has downstream business where it can secure a channel to the end use for its upstream products, but not only this, since it outsource the midstream it can make a deal with its midstream partners "source X musd wafers from us and we'll source X musd modules from you", which allows them to get a factor on how much each of their MW of downstream business can secure in MW of wafer sales and thus utilization of their upstream capacity.
SOL is doing similar thing, but focus less on projects (for projects they focus on plant ownership very selectively for high IRR rather than large volume EPC) and more on modules and system kits, so their deal with their cell partners is "source X musd wafers from us and we'll source X musd cells from you".
To me these models of capturing the margin benefits of upstream, but mitigating the flipside underutilization risk, have strength. It's a short leap to consider the possibility that GCL and SOL are conducting cell R&D to take that inhouse too, having superior modules and capture all the incremental gross profit in the poly to module value-chain while only having modules sales cost. But this step is not without risk, they need to have modules that are so easy to sell from their superiority that they can sell (after own use for downstream) volumes in the same size as their upstream capacity. Current model allows them to have twice the upstream capacity to their module market-share. So the net effect on profits of doing cells might not be positive unless cell superiority (at least combined with wafer superiority) can be achieved, thus it is a risk to enter that path compared with the safer partnership model they have today.
Klothilde, I would be interested in hearing more about your view on what model you think will accumulate profits best over full cycles (obviously during shortage its poly and during oversupply its EPC, but that does not mean full cycle profit retention, and its the retention power I'm looking for)? If we look at models like Trina and HSOL with inverted pyramid capacity (25% upstream, 100% midstream), which might become more like a diamond if they add EPC and YGE and JKS with full wafer and no poly (50% upstream, 100% midstream), these try to balance outsourcing costs and underutilization costs of upstream capacity. These models work well for that, but stuggels with purchased inventory carrying cost eating up profits and thus curbs the abilty to retain much over a full cycle, since to retain market-share during boom you are forced to build large stocks when component prices are high. These models are designed to enable growth not profits in my opinion. Now that SOL and GCL have cracked the code to super low capex and fast ramping for upstream they'll have the growth ability too at reasonable capital allocation.
My understanding is that you prefer upstream and downstream focus and your stock preference is FSLR. Why FSLR? Technology or project pipeline?